HBIO · Harvard Bioscience, Inc.

Summary

Harvard Bioscience, Inc. filed an 8-K on March 12, 2026, under Item 2.02 referencing Exhibit 99.1 Press Release, indicating disclosure of results of operations or earnings information not deemed 'filed' under Section 18 of the Securities Exchange Act. The filing includes Items 2.02 and 9.01 with Exhibit 99.1.

Key takeaways

• Form 8-K filed on 2026-03-12
• Item 2.02 - Results of Operations
• Exhibit 99.1 - Press Release issued March 12, 2026
• Item 9.01 - Financial Statements and Exhibits
• Exhibit 104 - Cover Page